Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients / Sollini, M; Kirienko, M; Cozzi, L; Torrisi, C; Antunovic, L; Tabacchi, E; Calderoni, L; Nanni, C; Alessi, A; Seregni, E; Fanti, S; Guidetti, A; Ricci, F; Corradini, P; Zinzani, P; Stella, Cc; Chiti, A. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 46:SUPPL 1(2019), pp. 154-154. (Intervento presentato al convegno 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) tenutosi a Barcelona, SPAIN nel OCT 12-16, 2019).
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients
Chiti AUltimo
2019-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
